RPTP Raptor Pharmaceuticals Corp

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Raptor Pharmaceutical Corp. to Horizon Pharma Plc for $9.00 Per Share

NEW YORK--(BUSINESS WIRE)--

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Raptor Pharmaceutical Corp. (“Raptor”) (NASDAQ: RPTP) stock prior to September 12, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Raptor to Horizon Pharma Plc (NASDAQ: HZNP) for $9.00 per share. To learn more about the action and your rights, go to:

http://zlk.9nl.com/raptor-pharmaceutical-rptp

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
15/09/2016

Underlying

RPTPRaptor Pharmaceuticals Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Raptor Pharmaceuticals Corp

 PRESS RELEASE
Free
RPTP Raptor Pharmace...

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Propo...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Raptor Pharmaceutical Corp. (NASDAQ: RPTP) (“Raptor” or the “Company”) relating to the proposed buyout of Raptor by Horizon Pharma plc. Under the terms of the agreement, Raptor shareholders are anticipated to receive $9.00 in cash for each share of Raptor common stock held. The ...

September 15, 2016 1 EN
 PRESS RELEASE
Free
RPTP Raptor Pharmace...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regar...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Raptor Pharmaceutical Corp. (“Raptor”) (NASDAQ: RPTP) stock prior to September 12, 2016. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Raptor to Horizon Pharma Plc (NASDAQ: HZNP) for $9.00 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/raptor-pharmaceutical-rptp ...

September 15, 2016 1 EN
 PRESS RELEASE
Free
RPTP Raptor Pharmace...

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Raptor Pharmaceutical Corp. (NASDAQ: RPTP) (“Raptor” or the “Company”) relating to the proposed buyout of Raptor by Horizon Pharma Plc. Under the terms of the agreement, Raptor shareholders are anticipated to receive $9.00 in cash for each share of Raptor common stock held. The ...

September 12, 2016 1 EN
 PRESS RELEASE
Free
RPTP Raptor Pharmace...

RAPTOR PHARMACEUTICAL CORP. SHAREHOLDER ALERT: Former SEC Attorney Wil...

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Raptor Pharmaceutical Corp. (“Raptor”) (NasdaqGM: RPTP) concerning the sale to Horizon Pharma plc. Under the terms of the agreement, Raptor shareholders will only receive $9.00 for each share owned, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $...

September 12, 2016 1 EN
 PRESS RELEASE
Free
RPTP Raptor Pharmace...

RAPTOR PHARMACEUTICAL CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of Raptor Pharmaceutical Corp. (NASDAQ GM: RPTP)? Did you purchase any of your shares prior to September 12, 2016? Do you think the proposed buyout price is too low? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (NA...

September 12, 2016 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch